The history of Sildenafil presents a complex case for stakeholders in the drug sector. While initially a tremendous success, producing billions, the intellectual property end and the subsequent entry of off-brand https://knockoff085268.getblogs.net/74397807/the-little-copyright-and-the-pharmaceutical-industry-a-risky-investment